使用纳米CRISPR支架的HO-1基因淘汰抑制了小鼠模型中的转移
Ning Wang1, Zichao Luo2,3,4,5, Chao Liu6
1Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Nature biomedical engineering
|October 22, 2025
概括
这项研究引入了一种新的基因编辑纳米平台,可以克服瘤对光动力学治疗的耐受性. 这种方法增强了癌症疫苗,使瘤易受反应性氧物种的影响,从而提高了免疫反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
背景情况:
- 光动力学疗法 (PDT) 诱导的免疫细胞死亡显示出对自身癌症疫苗的希望.
- 瘤对活性氧物种 (ROS) 的遗传耐受性限制了PDT的有效性.
- 开发克服瘤耐受性的策略对于有效的癌症免疫疗法至关重要.
研究的目的:
- 通过克服瘤遗传耐受性来开发癌症疫苗的可遗传纳米平台.
- 为了提高光动力学疗法诱导的免疫细胞死亡的疗效.
- 为了改善强大而持久的抗瘤免疫反应的产生.
主要方法:
- 使用纳米CRISPR/HO-1支架编辑血红素氧化酶-1 (HO-1) 的基因.
- 设计纳米平台与氨酸移植的聚乙烯胺和CpG图案.
- 在黑色素瘤小鼠模型中用抗PD-L1抗体进行组合治疗.
主要成果:
- 纳米CRISPR/HO-1支架消除了瘤对ROS的耐受性,在瘤后代中产生了可遗传的易感性.
- 该纳米平台增强了抗原生成,促进了T细胞的增殖,并激活了适应性免疫力.
- 与抗PD-L1联合治疗诱导了强大的抗瘤免疫力和耐久的免疫记忆 in vivo.
结论:
- 这种可遗传的纳米平台有效地克服了瘤对PDT的耐受性,增强了自身癌症疫苗的潜力.
- 工程纳米平台增强了癌症免疫循环和自适应性免疫反应.
- 这种方法为开发有效的癌症疫苗和组合免疫疗法提供了一个有希望的战略.
相关概念视频
02:43Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
01:16In-vitro Mutagenesis
16.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.0K